Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 13
2022 15
2023 13
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial.
Reis G, Augusto Dos Santos Moreira Silva E, Carla Medeiros Silva D, Thabane L, Santiago Ferreira T, Vitor Quirino Dos Santos C, Paula Figueiredo Guimaraes Almeida A, Cançado Monteiro Savassi L, Dias de Figueiredo Neto A, Lanna França Reis L, Helena de Souza Campos V, Bitarães C, Diniz Callegari E, Izabel Campos Simplicio M, Barra Ribeiro L, Oliveira R, Harari O, Forrest JI, Lat PK, Dron L, Thorlund K, Mills EJ. Reis G, et al. Am J Clin Nutr. 2024 Sep;120(3):602-609. doi: 10.1016/j.ajcnut.2024.06.016. Epub 2024 Aug 15. Am J Clin Nutr. 2024. PMID: 39232602 Clinical Trial.
BACKGROUND: Algae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clinical consequences to COVID-19 infections. ...The primary end point was hospitalization defined as either retention in a COVI …
BACKGROUND: Algae-derived nutraceuticals, such as spirulina, have been reported to have biological activities that may minimize clini …
Cyanobacterial and microalgae polymers: antiviral activity and applications.
da Silva MBF, Teixeira CMLL. da Silva MBF, et al. Braz J Microbiol. 2024 Dec;55(4):3287-3301. doi: 10.1007/s42770-024-01452-5. Epub 2024 Jul 15. Braz J Microbiol. 2024. PMID: 39008244 Review.
At the end of 2019, the world witnessed the beginning of the COVID-19 pandemic. As an aggressive viral infection, the entire world remained attentive to new discoveries about the SARS-CoV-2 virus and its effects in the human body. ...Polysacchar …
At the end of 2019, the world witnessed the beginning of the COVID-19 pandemic. As an aggressive viral infection, the entire w …
Microcystis viridis NIES-102 Cyanobacteria Lectin (MVL) Interacts with SARS-CoV-2 Spike Protein Receptor Binding Domains (RBDs) via Protein-Protein Interaction.
Wang Z, Yang Z, Shishido M, Daoudi K, Hidaka M, Tateno H, Futai E, Ogawa T. Wang Z, et al. Int J Mol Sci. 2024 Jun 18;25(12):6696. doi: 10.3390/ijms25126696. Int J Mol Sci. 2024. PMID: 38928400 Free PMC article.
The emergence of coronavirus disease 2019 (COVID-19) posed a major challenge to healthcare systems worldwide, especially as mutations in the culprit Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) complicated the development of vacc …
The emergence of coronavirus disease 2019 (COVID-19) posed a major challenge to healthcare systems worldwide, especially as mu …
Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV-2.
Matos-Hernández ML, Samples R, Dyer G, Casimir Montán VM, Morales-Colón CA, Salvino JM, Montaner LJ, Cassel JA, Messick TE, Tietjen I, Caro-Diaz EJE. Matos-Hernández ML, et al. J Nat Prod. 2024 Jun 28;87(6):1513-1520. doi: 10.1021/acs.jnatprod.3c01071. Epub 2024 May 23. J Nat Prod. 2024. PMID: 38781491
Current small-molecule-based SARS-CoV-2 treatments have limited global accessibility and pose the risk of inducing viral resistance. Therefore, a marine algae and cyanobacteria extract library was screened for natural products that could inhibit …
Current small-molecule-based SARS-CoV-2 treatments have limited global accessibility and pose the risk of inducing vira …
Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial.
Aghasadeghi MR, Zaheri Birgani MA, Jamalimoghadamsiyahkali S, Hosamirudsari H, Moradi A, Jafari-Sabet M, Sadigh N, Rahimi P, Tavakoli R, Hamidi-Fard M, Bahramali G, Parmoon Z, Arjmand Hashjin S, Mirzajani G, Kouhkheil R, Roshangaran S, Khalaf S, Khademi Nadoushan M, Gholamiyan Yousef Abad G, Shahryarpour N, Izadi M, Zendedel A, Jahanfar S, Dadras O, SeyedAlinaghi S, Hackett D. Aghasadeghi MR, et al. Front Immunol. 2024 Apr 8;15:1332425. doi: 10.3389/fimmu.2024.1332425. eCollection 2024. Front Immunol. 2024. PMID: 38655258 Free PMC article. Clinical Trial.
However, the effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19 is currently unclear. This study aimed to evaluate the efficacy and safety of high-dose Spirulina platensis for SARS-CoV-2 infection. ...CONCLUSION: …
However, the effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19 is currently unclear. This stu …
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Causes of Death Collaborators. GBD 2021 Causes of Death Collaborators. Lancet. 2024 May 18;403(10440):2100-2132. doi: 10.1016/S0140-6736(24)00367-2. Epub 2024 Apr 3. Lancet. 2024. PMID: 38582094 Free PMC article.
Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemi …
Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new ag …
Antiviral discovery in toxic cyanobacteria: Low hanging fruit in the age of pandemics.
Zheng S, Lee V, Meza-Padilla I, Nissimov JI. Zheng S, et al. J Phycol. 2024 Apr;60(2):574-580. doi: 10.1111/jpy.13425. Epub 2024 Jan 4. J Phycol. 2024. PMID: 38174634
The power of novel vaccination technologies and their rapid development were elucidated clearly during the COVID-19 pandemic. At the same time, it also became clear that there is an urgent need to discover and manufacture new antivirals that target emerging viral th …
The power of novel vaccination technologies and their rapid development were elucidated clearly during the COVID-19 pandemic. …
[Up to Date of Cyanobacterial Natural Products].
Okino T. Okino T. Yakugaku Zasshi. 2024;144(1):27-32. doi: 10.1248/yakushi.23-00161-2. Yakugaku Zasshi. 2024. PMID: 38171790 Free article. Japanese.
Recently genome-based analyses by Piel led to the discovery of novel compounds from cyanobacteria. W. H. Gerwick found a potential as anti-SARS-CoV-2 agent in gallinamide A, which was reported as a cathepsin L inhibitor. ...OSMAC and genome-based scree …
Recently genome-based analyses by Piel led to the discovery of novel compounds from cyanobacteria. W. H. Gerwick found a potential as …
50 results